Xeltis’ bioabsorbable pulmonary heart valve has been nominated for the 2017 Edison Awards. The Edison Awards honor innovation and excellence in the development of new products and services.
In the true spirit of globally renowned inventor Thomas Edison, the Edison Awards look for active contributors to the cause and purpose of innovation in the world. The Awards are in their 30th edition.
“The Edison Awards’ mission is to recognize innovation that can create a positive impact in the world. At Xeltis we are working to revolutionize cardiovascular treatment. Our objectives are aligned and it is an honor to be among the nominees,” Xeltis CEO Laurent Grandidier commented.